ARMS-I (a Formulation of Cetylpyridinium Chloride -CPC)

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2017

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Viral Upper Respiratory Tract Infection
Interventions
DRUG

ARMS-I

Trial Locations (1)

43606

ProMedica Health System, Toledo

All Listed Sponsors
collaborator

ProMedica Health System

OTHER

collaborator

The University of Toledo

UNKNOWN

collaborator

ARMS Pharmaceutical LLC

UNKNOWN

collaborator

Pediatric Pharmacology Research Center

UNKNOWN

lead

University of Toledo Health Science Campus

OTHER